Mesa Laboratories, Inc.
MLABTechnologyNASDAQScientific & Technical Instruments
Scan Results
Daily timeframeMesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. Valued at $589.3M, MLAB is a small-cap name in its sector. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Market Cap
$589.3M
Beta
0.94
P/E (TTM)
88.15
P/E (Fwd)
8.69
EPS (TTM)
$1.21
EPS (Fwd)
$12.27
ROE
3.9%
ROA
2.7%
Cash
$26.9M
Total Debt
$0
Free CF
—
52W Change
5.7%
Annual Financials
Cash vs Debt
Mesa Laboratories, Inc. reports $26.9M in cash and $0 in total debt. Return on equity stands at 3.9%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $184.3M (2022) to $241.0M (2025), reflecting a 31% increase over the period.
The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MLAB.